A Novel Skin Cream Containing a Mixture of Human Growth Factors and Cytokines for the Treatment of Adverse Events Associated with Photodynamic Therapy
September 2006 | Volume 5 | Issue 8 | Case Report | 796 | Copyright © 2006
Michael H. Gold MD, Julie Biron
Background and Objectives: Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) is becoming a more popular dermatologic procedure. Newer protocols have virtually eliminated any associated untoward effects. Phototoxicity, although rare, can still occur and requires aggressive post-therapy care. Recently, a new biorestorative skin care cream, containing human growth factors and cytokines, was used to treat 2 severe cases of PDT-associated phototoxicity. Materials and Methods: This paper describes 2 case reports of severe phototoxicity following ALA-PDT treatments. The novel skin care cream was utilized in both cases phototoxicity. Results: Complete resolution of the phototoxic reaction was seen, leaving both patients with normal skin texture and tone. Conclusions: This novel skin care cream may prove useful in wound healing following treatment with lasers and light sources or dermatologic surgery.
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close